Thio-Tepa Therapy to Prevent Postoperative Pterygium Occurrence and Neovascularization

Picó, G.: Pterygium. Current concepts of etiology and management. Tr. Cornea World Conference. London, Butterworth, 1965, p. 280. Langham, 1960, The inhibition of corneal vascularization by triethylene thiophosphoramide, Am. J. Ophth., 49, 1111, 10.1016/0002-9394(60)91621-4 Meacham, 1962, Triethylene thiophosphoramide in the prevention of pterygium recurrence, Am. J. Ophth., 54, 751, 10.1016/0002-9394(62)94154-5 Cassady, 1966, The inhibition of pterygium recurrence by Thio-TEPA, Am. J. Ophth., 61, 886, 10.1016/0002-9394(66)90930-5 Liddy, 1966, Triethylene thiophosphoramide (Thio-TEPA) and pterygium, Am. J. Ophth., 61, 888, 10.1016/0002-9394(66)90931-7 Joselson, 1966, Incidence of pterygium recurrence in patients treated with Thio-TEPA, Am. J. Ophth., 61, 891, 10.1016/0002-9394(66)90932-9 Ey, 1968, Prevention of corneal vascularization, Am. J. Ophth., 66, 1118, 10.1016/0002-9394(68)90821-0 Rock, 1963, Inhibition of corneal vascularization by tri-ethylene thiophosphoramide (Thio-TEPA), Arch. Ophth., 69, 330, 10.1001/archopht.1963.00960040336015 Mori, 1962, A new treatment of pterygium, Acta Soc. Ophth. Jap., 66, 990